AIMS MEDICAL has been awarded the ACCIÓ Open and Disruptive Innovation Projects Grant 2025, under the L2 line – Development Projects for Emerging Companies (Start-ups) (ACE139/24/000347).
This program, promoted by ACCIÓ – the Agency for Business Competitiveness of the Government of Catalonia, supports startups in validating their products, services, or technologies through pilot tests carried out in collaboration with established organizations. The grant also enables the design and prototyping of a minimum viable product (MVP) to accelerate its entry into the market.
Through this initiative, AIMS MEDICAL will continue advancing the development and validation of its AI-based medical diagnostic solutions, reinforcing our commitment to innovation, patient safety, and the digital transformation of healthcare.
Receiving this grant reinforces AIMS MEDICAL’s position as a leading healthtech startup in Catalonia, committed to transforming clinical decision-making through evidence-based and responsible artificial intelligence innovation.